Login to Your Account



Genzyme, Now In Front For AnorMED, Reports Earnings

By Aaron Lorenzo


Friday, October 13, 2006
Genzyme Corp., which has moved to the forefront of a bidding war for AnorMED Inc., on Thursday reported third-quarter earnings that came out ahead of consensus projections but nonetheless failed to impress many observers. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription